Despite the threat of a 200% tariff, most pharma stocks remained stable. US President Donald Trump’s 200% tariff threat on the pharmaceutical industry is a “shock” that will reverberate through global ...

MediView has announced the first patient enrolment in a study to assess the XR90 Holographic Surgical Navigation system.

Companion Spine has entered a definitive agreement to acquire Paradigm Spine’s business and assets from Xtant Medical Holdings.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Mendaera’s Focalist, a handheld robotic system.

BVI is a winner in the Research and Development, Investments, and Product Launches categories in the 2025 Medical Device ...

Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...

CorFlow Therapeutics is set to initiate a pivotal trial of its CorFlow CoFl system across US hospitals for heart attack.

Morphic Medical has obtained an EU CE mark for RESET, a device designed to target the underlying cause of obesity and type 2 diabetes (T2D).

Miach Orthopaedics has completed the enrolment for the BEAR MOON study, which compares the collagen-based BEAR Implant.

The US FDA has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse Pulsed Field Ablation (PFA) System.

US-based PanTher Therapeutics has initiated a trial of its chemotherapy-eluting patch, which it hopes will make cancer therapy more tolerable.

The Chinese Ministry for Commerce said the “EU has insisted on taking restrictive measures to build new protectionist barriers”.